(Total Views: 806)
Posted On: 05/07/2020 9:28:52 PM
Post# of 153986
Here's the comment from NYT.
I
InpatientlyWaiting
Philadelphia26m ago
We have spent so much time on the hydroxychloroquine debate - and at the same time I haven’t seen word one in the Times about the HIV drug Leronlimab that actually saved a lot of lives in phase one clinical trials treating COVID. It’s also now being examined as a possible treatment for the kids experiencing Kawasaki-like symptoms. This could be a huge turning point. It makes my heart swell.
But without any major press coverage, phase 2/3 trials are filling up slowly, so we must wait while thousands if not tens of thousands more die. Meanwhile penny stock investors are ripping apart the company with tabloid headlines every night to short it again the next morning. It is devastating to see a drug that is literally saving lives not get the public awareness it needs to get to the public.
I
InpatientlyWaiting
Philadelphia26m ago
We have spent so much time on the hydroxychloroquine debate - and at the same time I haven’t seen word one in the Times about the HIV drug Leronlimab that actually saved a lot of lives in phase one clinical trials treating COVID. It’s also now being examined as a possible treatment for the kids experiencing Kawasaki-like symptoms. This could be a huge turning point. It makes my heart swell.
But without any major press coverage, phase 2/3 trials are filling up slowly, so we must wait while thousands if not tens of thousands more die. Meanwhile penny stock investors are ripping apart the company with tabloid headlines every night to short it again the next morning. It is devastating to see a drug that is literally saving lives not get the public awareness it needs to get to the public.
(4)
(0)
